OPK Q4 2024 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena

OPKOPKO Health, Inc.

$933M

Q4 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$184M+1.0% YoY

Gross Profit

$85M46.1% margin

Operating Income

-$33M-18.0% margin

Net Income

$14M7.6% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+5.8%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$50M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$835M

Stockholders' Equity

$1.4B

Cash & Equivalents

$432M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$184M	$182M	+1.0%
Gross Profit	$85M	$45M	+89.4%
Operating Income	-$33M	-$69M	+52.0%
Net Income	$14M	-$66M	+121.1%

Revenue Segments

Service

$103M56%

Transfer of Intellectual Property and Other

$43M23%

Product

$37M20%

Geographic Segments

UNITED STATES

$136M74%

IRELAND

$18M10%

CHILE

$16M9%

SPAIN

$7M4%

MEXICO

$5M3%

ISRAEL

$975,0001%

Other Countries

$933,0001%